eHealth stock gained 11.45 percent as director sold shares while market reset expectations

Published on 10/08/2026 at 06:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

eHealth stock gained 11.45 percent to USD 0.76 on October 6, 2026. A director sold 40,612 shares, while Q2 revenue reached USD 33.57 million.

EHTH, US28238P1093, Illustration mit AI erstellt.

eHealth stock (ISIN US28238P1093) gained 11.45 percent to USD 0.76 on Nasdaq on October 6, 2026. The move came as director Francis Soistman Jr. sold 40,612 shares in transactions dated October 1 and October 2, according to Investing.com on October 3, 2026.

Director sold 40,612 shares

Soistman sold 20,306 shares on October 1 at a weighted average price of USD 0.6962 and another 20,306 shares on October 2 at USD 0.6913. The combined transactions were worth USD 28,174 and followed a Rule 10b5-1 trading plan adopted on June 1, 2026, Investing.com reported.

Following the sales, Soistman beneficially owned 974,609 eHealth shares. The transaction therefore adds a concrete insider-selling signal to a stock whose October 6 market capitalization stood at USD 24.3 million.

Q2 loss widened as revenue fell

For the second quarter of 2026, eHealth reported revenue of USD 33.57 million, down 45 percent from the year-earlier quarter, while diluted EPS was negative USD 1.18 against consensus of negative USD 0.84, according to MarketBeat.

The USD 0.34 EPS shortfall contrasts with revenue that exceeded the USD 33.28 million analyst estimate cited by MarketBeat. The combination leaves the next earnings report as the more important test of whether enrollment activity can offset the second-quarter revenue decline.

Consensus target remains above USD 0.76

MarketBeat lists a Reduce consensus based on six analysts, including five Hold ratings and one Sell rating. Its average price target is USD 2.19, with a high of USD 3.00 and a low of USD 1.75.

The average target lies 188.1 percent above the October 6 price of USD 0.76. That wide gap reflects the distance between the market valuation and analyst expectations, but the Q2 loss and insider sale remain concrete counter-factors for investors assessing the turnaround.

Stock remains near its yearly low

eHealth stock was last at USD 0.76 on Nasdaq on October 6, 2026, with a 52-week range of USD 0.65 to USD 5.89. Trading volume was 572,526 shares, giving the price a position 16.9 percent above the yearly low.